Development of an ultra-performance liquid chromatography technique coupled with mass spectrometry for the measurement of tacrolimus in micro-samples of whole blood, and its application on a pharmacokinetic trial

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 10, 2007, Pages 659-664

  Marcelín Jiménez, Gabriel ^a,b   García González, Alberto ^a   Ángeles Moreno, Alionka P ^a   Contreras Zavala, Leticia ^a   Rivera, Liliana ^a   Morales, Miriam ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

Author keywords

CAS 104987 11 3; Immunosuppressive agents; Mass spectrometry; Tacrolimus, measurement in whole blood, pharmacokinetics; Ultra performance liquid chromatography

Indexed keywords

EDETIC ACID; FRAMEBIN; HEPARIN; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEXICO; NORMAL HUMAN; ORGAN TRANSPLANTATION; PILOT STUDY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE;

EID: 35948967536     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296665     Document Type: Article

References (12)

1. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporine A and FK506. Immunol Today. 1992;13:136-142.
2. Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, et al. Multicenter randomized trial comparing FK506 and cyclosporine in the prevention of renal allograft rejection. Transplantation. 1997;64:436-443.
3. Bekersky I, Dressler D, Mekki QA. Dose linearity after oral administration of tacrolimus 1 mg capsules at doses of 3, 7 and 10 mg. Clin Ther. 1999;21:2058-2064.
4. Iwasaki K, Shiraga T, Matsuda H, Nagase K, Tokuma Y, Hata T, et al. Further metabolism of FK506. Identification and biological activities of the metabolites oxidized at multiple sites of FK506. Drug Metab Dispos. 1995;23:28-34.
5. Taylor PJ, Jones A, Balderson GA, Lynch SV, Norris RL, Pond SM. Sensitive, specific quantitative analysis of tacrolimus in blood by liquid chromatography - electrospray tandem mass spectrometry. Clin Chem. 1996;42:279-285.
6. Streit F, Armstrong VW, Oellerich M. Rapid liquid chromatography - tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus and cyclosporine A in whole blood. Clin Chem. 2002;48:955-958.
7. Ramakrishna NVS, Vishwottam KN, Puran S, Manoi S, Santosh M, Wishu S, et al. Liquid chromatography - negative ion electrospray tandem mass spectrometry method for the quantification of tacrolimus in human plasma and its bioanalytical applications. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jun 5;805:13-20.
8. Wang B, Magill JE, Faye B, Vicente BS. A fast and simple HPLC/mass spectrometry method for simultaneous measurement of whole blood tacrolimus and sirolimus. Arch Pathol Lab Med. 2005;129:661-665.
9. Pruebas y procedimientos para demostrar intercambiabilidad de formulaciones farmaceúticas. Secretaría de Salud de México. NOM-177-SSA1-1998.
10. Guidance for Industry. Statistical Approaches to Establishing Bioequivalence. FDA (CDER). US Department of Health and Human Services; January 2001.
11. Machida M, Takahara S, Ishibashi M, Hayashi M, Sekihara T, Yamanaka H. Effect of temperature and hematocrit on plasma concentration of FK-506. Transplant Proc. 1991;23: 2753-2754.
12. Bekersky I, Dressier D, Mekki QA. Dose linearity after oral administration of tacrolimus 1 mg capsules at doses of 3, 7, and 10 mg. Clin Ther. 1999;21:2058-2064.